Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pouletty

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Clinical Pharmacology|September 30, 1998
Comparison of two cyclosporine formulations in healthy volunteers: bioequivalence of the new Sang-35 formulation and NeoralT J Schroeder, M J Cho, G M Pollack, et al.
Pharmacology|August 18, 1999
An individual bioequivalence approach to compare the intrasubject variability of two ciclosporin formulations, SangCya and NeoralD M Canafax, W D Irish, H B Moran, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 19, 1998
Proposed consensus for definitions and endpoints for clinical trials of acute kidney transplant rejectionR D Guttmann, J P Soulillou, L W Moore, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1985
Lymphadenopathy in patients at risk for acquired immunodeficiency syndrome. Histopathology and histochemistryM Raphael, P Pouletty, M Cavaille-Coll, et al.
Tissue Antigens|July 1, 1993
Typing of serum-soluble HLA-B27 antigen by ELISAP Pouletty, C Chang, J Kalil, et al.
Transplantation|April 15, 1997
Decreased cytotoxic activity of natural killer cells in kidney allograft recipients treated with human HLA-derived peptideM Giral, M C Cuturi, J M Nguyen, et al.
Transplantation Proceedings|February 1, 1995
Decamer peptide derived from the alpha 1 helix of the first domain of HLA-B7 01 prolongs allograft survival in rats with an inhibition of graft infiltrating cell cytotoxicityM C Cuturi, R Josien, D Cantarovich, et al.
Transplantation|March 15, 1995
Prolongation of allogeneic heart graft survival in rats by administration of a peptide (a.a. 75-84) from the alpha 1 helix of the first domain of HLA-B7 01M C Cuturi, R Josien, P Douillard, et al.
Transplantation Proceedings|February 1, 1997
A multicenter report on the utilization of Banff grading in acute renal rejection. The 1995 Efficacy Endpoints ConferenceL W Gaber, L W Moore, A O Gaber, et al.
Transplantation|March 4, 1998
Utility of standardized histological classification in the management of acute rejection. 1995 Efficacy Endpoints ConferenceL W Gaber, L W Moore, A O Gaber, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Clinical Pharmacology|September 30, 1998
Comparison of two cyclosporine formulations in healthy volunteers: bioequivalence of the new Sang-35 formulation and NeoralT J Schroeder, M J Cho, G M Pollack, et al.
Pharmacology|August 18, 1999
An individual bioequivalence approach to compare the intrasubject variability of two ciclosporin formulations, SangCya and NeoralD M Canafax, W D Irish, H B Moran, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 19, 1998
Proposed consensus for definitions and endpoints for clinical trials of acute kidney transplant rejectionR D Guttmann, J P Soulillou, L W Moore, et al.
Archives of Pathology & Laboratory Medicine|February 1, 1985
Lymphadenopathy in patients at risk for acquired immunodeficiency syndrome. Histopathology and histochemistryM Raphael, P Pouletty, M Cavaille-Coll, et al.
Tissue Antigens|July 1, 1993
Typing of serum-soluble HLA-B27 antigen by ELISAP Pouletty, C Chang, J Kalil, et al.
Transplantation|April 15, 1997
Decreased cytotoxic activity of natural killer cells in kidney allograft recipients treated with human HLA-derived peptideM Giral, M C Cuturi, J M Nguyen, et al.
Transplantation Proceedings|February 1, 1995
Decamer peptide derived from the alpha 1 helix of the first domain of HLA-B7 01 prolongs allograft survival in rats with an inhibition of graft infiltrating cell cytotoxicityM C Cuturi, R Josien, D Cantarovich, et al.
Transplantation|March 15, 1995
Prolongation of allogeneic heart graft survival in rats by administration of a peptide (a.a. 75-84) from the alpha 1 helix of the first domain of HLA-B7 01M C Cuturi, R Josien, P Douillard, et al.
Transplantation Proceedings|February 1, 1997
A multicenter report on the utilization of Banff grading in acute renal rejection. The 1995 Efficacy Endpoints ConferenceL W Gaber, L W Moore, A O Gaber, et al.
Transplantation|March 4, 1998
Utility of standardized histological classification in the management of acute rejection. 1995 Efficacy Endpoints ConferenceL W Gaber, L W Moore, A O Gaber, et al.
Pageof 5